Skip to main content
. Author manuscript; available in PMC: 2017 Jul 24.
Published in final edited form as: Hypertens Res. 2013 Oct 3;37(2):116–124. doi: 10.1038/hr.2013.129

Figure 6.

Figure 6

Right ventricular (RV) hypertrophy and myocardial fibrosis is inhibited by NPS2143 in monocrotaline (MCT)-pulmonary hypertension (PH) rats. Averaged Fulton index (RV/LV+S ratio, mean±s.e.) (a) and Rise in ratio of RV/LV+S (b) showing that RV hypertrophy is significantly inhibited in MCT-PH rats treated with NPS2143. *P<0.05 vs. MCT alone. Representative Masson staining images (c) and summarized data (d) showing that NPS2143 attenuated myocardial fibrosis in the right ventricles of MCT-PH rats. **P<0.01 vs. MCT alone. LV, left ventricular. A full color version of this figure is available at the Hypertension Research journal online.